The prevalence of obesity is increasing worldwide, and the rates have more than doubled since 1980 (1). World Health Organization (WHO) defines overweight and obesity as "abnormal or excessive fat accumulation that may impair health" (1). Body Mass Index (BMI) is commonly used to classify overweight kg/m 2 ), obesity (BMI ≥ 30.0 kg/m 2 ), and super obesity (BMI ≥ 40.0 kg/m 2 ) (2). WHO further categorizes obesity into three classifications: Obesity Class I (BMI range from 30 to 34.99), Obesity Class II (BMI range from 35 to 39.99), and Obesity Class III (BMI ≥ 40) (3) but does not differentiate between Obesity Class I, Obesity Class II, and Obesity Class III in relation to weight-gain recommendations for pregnant women (4). Obesity in reproductive-aged women has become a serious health issue (5). Further, a growing body of evidence demonstrates that pre-pregnancy obesity is associated with both adverse maternal and neonatal outcomes (6,7).
of obesity increases. It remains unclear whether recommendations for gestational weight gain should differ for each obesity classification. It is, therefore, important to examine the incidence of negative maternal and neonatal outcomes for each obesity class to supply evidence as to the total gestational weight gain needed, based on variations among obesity classifications. Publication of the latest IOM guidelines for gestational weight gain marked an important development in prenatal care. To date, no published study has offered baseline data on the pattern of gestational weight gain prior to release of these guidelines. The purpose of this study, therefore, is to explore associations between excessive gestational weight gain and maternal and neonatal outcomes among obese women, stratified by severity of obesity. Additionally, we examine the patterns of gestational weight gain among obese women prior to the publication of the latest IOM guidelines. These baseline data will allow for future comparison of the effectiveness of the latest IOM guidelines for addressing gestational weight gain among the three classes of obese women. The research questions that guide this study are as follows:
1 We calculated a maternal weight-gain variable by subtracting pre-pregnancy weight from weight at time of delivery. Gestational weight gain is important for optimal maternal and neonatal outcomes. The 2009 IOM recommendation for gestational weight gain varies according to pre-pregnancy weight categories ( Table 1) . As noted, for obese women, the IOM recommends a gestational weight gain of 11-20 lbs. Our focus was the obese women who exceeded this recommendation. For a comparison group, we used obese women who gained within the IOM recommendation. We considered the following adverse pregnancy outcomes for the mother: gestational diabetes, preeclampsia, eclampsia, and C-section delivery. We considered the following adverse outcomes for the neonate: admission to the NICU, assisted ventilation for 6 hours or greater, antibiotics for the newborn with suspected sepsis, and surfactant therapy, information about all of which is found in the birth certificate data. Cases that did not provide pre-pregnancy weight, weight at delivery or maternal height were removed from the data set because without these variables, pre-pregnancy BMI and BMI at delivery could not be calculated. A total of 8393 cases was removed from the full data set due to the lack of one or more of these variables, leaving an obese population comprised of 410,635 cases for the five years examined. Frequencies were tabulated on the two gestational weightgain categories: within the recommended weight gain and above the recommended weight gain. To determine the trends of maternal and neonatal outcomes for each obesity class, we also calculated the frequencies of the four selected maternal outcome measures and of the four neonatal outcome measures. All analyses were conducted in SPSS, Version 19.
Results
To obtain rates for the three obesity classes in regard to the IOM gestational weight-gain ranges, we calculated frequencies and percentages (Table 1) . Of the obese women, 57.1% exceeded the recommended IOM gestational weight gain of 11-20 lbs. For all three obesity classes, the greatest percentage of women fell into the higher gestational weight-gain classification, that of greater than 20 lbs. For Obesity Class I, almost two-thirds (62.5%) of the women gained more than the IOM recommendation. Gestational weight-gain trends for all three obesity classifications indicated fluctuation over the five-year period (Table 2) . For all three obesity classifications, the percentage of those who exceeded the recommended gestational weight gain was 2-2.5 times greater than the percentage of those who gained within the recommendation. For Obesity Class I, those who gained greater than the IOM recommendation of 11-20 lbs, represented 62.1-63% of the obese women in that classification over the five-year period of 2005-2009. For Obesity Class II, those who gained greater than the IOM recommendation represented 52.7-53.9% of the obese women in that classification over the fiveyear period. For Obesity Class III, those who exceeded the IOM weight recommendation represented 43.5-44.2% of the women in that classification for the five-year period. For Obesity Classes I and II, the greatest percentage of women who exceeded the recommended weight gain fell in the year 2007. For Obesity Class III, the greatest percentage of women who exceeded the recommended weight gain fell in the year 2006. Evaluation of maternal outcomes for each obesity classification demonstrated that those who exceeded the recommended weight gain had higher percentages of pre-eclampsia and C-section delivery. Incidence of eclampsia in Obesity Classes I and II was twice as high in the group who exceeded the recommended weight gain than the group who gained within the weight recommendation. For Obesity Class III, there was no difference. Interestingly, the findings for gestational diabetes for all three obesity classes revealed that those who exceeded the recommended weight gain had lower incidence of gestational diabetes as compared with those who gained within the weightgain recommendation (Table 3) . Examination of neonatal outcomes indicated that the incidence of macrosomia was higher in newborns of women who exceeded the recommended weight gain for all three obesity classes. In Obesity Classes I and II, the incidence of NICU admission, surfactant therapy, antibiotics for suspected sepsis, and assisted ventilation 6 hours or greater was the same or lower for newborns of women who exceeded the recommended weight gain as compared with those who gained within the recommendation. In Obesity Class III, for all the selected neonatal outcomes, incidence was higher among newborns of women who gained greater than the IOM recommendation (Table 4) .
Discussion
Pre-pregnancy obesity is a serious public health issue. In our cohort of 410,635 women classified as obese, we examined women who gained above the IOM recommended gestational weight gain compared to those who gained within the recommendation. In our group of obese women, we found that approximately 3 out of 5 gained above the gestational weight gain recommended by the IOM, similar to the findings of Boyle et al. (12) . This finding is also in keeping with that of Johnson et al., who found that approximately 3 out of 4 of the women in their group of nulliparous women, who may or may not have been obese, (14) . Further, we found that women in Obesity Class I had the highest percentage of weight gain above the recommendation, indicating that women who are less obese are more likely to exceed the recommended weight gain. This is in line with the findings reported by Bodnar et al. (15) . One possible explanation for this finding is that severely obese women are more likely than less obese women to closely watch their weight gain during pregnancy. More studies are needed to further validate this supposition; however, our finding serves as caution to practitioners to monitor less obese women's gestational weight gain more closely.
Of the maternal outcomes that we examined, including gestational diabetes, pre-eclampsia, eclampsia, and C-section delivery, we found that the incidence of these outcomes was higher in Obesity Class III in both women who gained within and those who gained above IOM recommendations. Blomberg found that women in Obesity Classes II and III who lost weight during pregnancy had a decreased risk for C-section delivery and an unaffected risk for preeclampsia (16) . Although we examined women who gained weight during pregnancy, we found that there was a higher incidence of adverse maternal outcome in Obesity Classes II and III for those who gained above the IOM recommendation. We found that the incidence of C-section delivery increased as the severity of obesity increased and that the incidence was higher among women who gained above the IOM recommendation as compared to those who gained within the recommendation. In contrast to the Blomberg study (16), we found that the incidence of pre-eclampsia increased as the severity of the obesity increased. Oza-Frank and Keim found that women with excessive gestational weight gain were more likely to have preeclampsia than were women with inadequate weight gain (17) . However, the incidence of gestational diabetes among obese women who exceeded the IOM recommendation was lower than those who gained within the IOM recommendation. This was true for all three obesity classifications. Beyerlein et al. reported similar findings with regard to gestational diabetes in obese women who gained weight (18) . Comparable to the findings of Langford et al. (19) , we found that the incidence of pre-eclampsia, C-section delivery, and macrosomia increased as gestational weight gain increased, across all three obesity classifications. To add to the evidence on the connection between gestational weight gain and pregnancy outcomes, our study examined several neonatal outcomes: NICU admission, surfactant therapy, antibiotics for newborn with suspected sepsis, and assisted ventilation 6 hours or greater, which have not been reported in the literature (13, 15, 16, 19) .
In conclusion, gestational weight gain above the IOM recommendation is linked to higher incidence of pre-eclampsia, eclampsia, C-section delivery, and macrosomia. Further, incidence of all neonatal outcomes examined was higher in the group with weight gain above the IOM recommendation. Our study indicated that women in Obesity Class III were less likely to exceed the IOM recommendation on gestational weight gain but were more likely to have adverse outcomes. This finding confirms evidence from extant literature that the impact of pre-pregnancy 
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obesity on maternal and neonatal outcomes increases as the severity of obesity increases. This study has several limitations. Firstly, the data were derived from the state of Texas birth certificates. Researchers did not abstract data manually from the prenatal or post-partum records and were limited to using the data elements available in the birth certificate data set. Secondly, the study did not include the neonatal outcomes of small for gestational age and large for gestational age neonates, outcomes often measured when examining gestational weight gain (20) . Thirdly, the researchers used only descriptive statistics to characterize the study population; thus, no causal inferences could be made in regard to the relationship between gestational weight gain and maternal and neonatal outcomes. Another limitation was that there were cases within the birth certificate data file that were missing one or both of the variables needed to calculate pre-pregnancy weight and BMI. We, therefore, removed those cases from the analysis. A total number of 8393 cases with missing data was removed, approximately two percent of the total cases meeting the criteria to be included in the study sample.
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